About B3B

This author has not yet filled in any details.
So far B3B has created 228 blog entries.

Spotlight: Interrogating the Immune System for Diagnosing Infection

Startup Inflammatix, founded in 2016 in Burlingame, California, takes a different approach to diagnosing infections. Rather than seeking the pathogen causing the infection, it uses a data-driven approach to evaluate the body’s immune system response to provide a diagnosis in as little as an hour. Big3Bio editor Marie Daghlian spoke with Dr. Timothy Sweeney, co-founder [...]

March 9th, 2018|

Event Recap: PMWC2018 — Artificial Intelligence Takes Center Stage

By Marie Daghlian The buzz around artificial intelligence, or AI, is palpable—similar to the buzz around CRISPR and immuno-oncology just a few years ago. VCs are throwing money at startups that are using AI. Proponents say it can solve the world’s problems, do what humans cannot. Others worry that it will run away from humans, [...]

February 5th, 2018|

Charles River’s 2nd Annual Viral Safety and Viral Clearance Summit

Charles River’s 2nd Annual Viral Safety and Viral Clearance Summit will be held October 10 – 11, 2017 at the San Mateo Marriott in San Mateo, CA. The 2-day summit, located in the Bay Area, unites industry professionals in an interactive setting to share updates and discuss trends in the realm of viral safety and [...]

August 3rd, 2017|

Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development Symposium

The Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development symposium will be held September 11-13, 2017 at Cape Rey Resort, Carlsbad, CA. This three-day symposium with five sessions has a jam-packed agenda with case study presentations from industry leaders from Bluebird, Janssen, Pfizer and Amgen in the nonclinical development of biotherapeutics. Don’t miss out on [...]

July 18th, 2017|

Spotlight: Every Challenge. Every Day. Every Voice.

Behind every patient stands thousands of scientists and researchers working together to develop life-saving treatments. So what happens when a patient meets the people that helped save her life? Watch this 8-minute documentary as Ginger Tam, a lung-cancer patient, meets the researchers who worked on her cancer treatment.  

March 1st, 2017|

Event Recap: PMWC 2017

Shaping Patient-Centric Health Care By Marie Daghlian Rapid advances in genomics and technology are transforming personalized medicine into precision medicine. Genomic medicine is here, Euan Ashley said as he welcomed a gathering of more than 8,000 people to the Precision Medicine World Conference (PMWC) held in Silicon Valley. Ashley, director of Stanford University’s Clinical Genomics [...]

February 6th, 2017|

Event Recap: BioWeekSF Spotlight – Rare in the Square/Biotech Showcase Panel

Developing Therapies for Rare Diseases: Patients Come First By Marie Daghlian Rare disease drug development is personal and often driven by patient advocacy. In a lively and engaging fireside chat titled “Unmet needs, uncommon commitment: shift toward investment in rare diseases,” Henri Termeer, an early advocate of rare disease drug development and a serial entrepreneur, [...]

January 23rd, 2017|

Event Recap: Biotech Showcase 2017 – “Looking Ahead” Workshop Focus

Upbeat Mood but Uncertainty Ahead By Marie Daghlian The Hilton Hotel at Union Square in downtown San Francisco hummed with energy as more than 3,300 life sciences professionals converged for the ninth annual Biotech Showcase during the second week of January 2017. Held at the same time as the annual J.P. Morgan Healthcare Conference, neither [...]

January 23rd, 2017|